Two majors congresses for epilepsy drug discovery are taking place this May in the USA, and of course we will be there! First will be held the Antiepileptic Drug and Device (AED) Trials XIII Conference in Miami on May 13 to 15, followed from May 17 to 20 by the ADD symposium in Park city, Utah.
ADD Symposium’s goal is to explore how innovative breakthroughs in basic science can be leveraged by public, federal, and private partnerships to rapidly develop new treatments for the patient with epilepsy. ADD symposium wishes to facilitate new knowledge, new collaborations, and new insight into state of the art of therapy development
SynapCell will be attending both meeting, presenting talks about our new solutions for epilepsy drug discovery. We are excited to meet you there!